ReviewMolecular diagnosis & therapy2022

Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option.

Athena Starlard-Davenport et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.